tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALVR Stock Latest News

AlloVir Finalizes $7 Million Lease Termination Deal
Company AnnouncementsAlloVir Finalizes $7 Million Lease Termination Deal
3M ago
8K
ALVR
AlloVir Ends Lease Agreement with AMAG Pharmaceuticals
PremiumCompany Announcements
AlloVir Ends Lease Agreement with AMAG Pharmaceuticals
3M ago
8K
ALVR
AlloVir Approves Executive Bonuses for Potential 2024 Buyout
PremiumCompany Announcements
AlloVir Approves Executive Bonuses for Potential 2024 Buyout
4M ago
8K
ALVR
SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
PremiumClass Action
SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
7M ago
ALVR
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
PremiumCompany Announcements
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
7M ago
8K
ALVR
Allovir Inc (ALVR) Q4 Earnings Cheat Sheet
PremiumPre-EarningsAllovir Inc (ALVR) Q4 Earnings Cheat Sheet
8M ago
ALVR
SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
Premium
Class Action
SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
8M ago
ALVR
Morgan Stanley lowers AlloVir to Underweight after discontinuations, job cuts
Premium
The Fly
Morgan Stanley lowers AlloVir to Underweight after discontinuations, job cuts
9M ago
ALVR
AlloVir downgraded to Underweight from Equal Weight at Morgan Stanley
PremiumThe Fly
AlloVir downgraded to Underweight from Equal Weight at Morgan Stanley
9M ago
ALVR
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
PremiumThe Fly
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
9M ago
ARM
BMY
AlloVir downgraded to Underperform from Buy at BofA
PremiumThe Fly
AlloVir downgraded to Underperform from Buy at BofA
9M ago
ALVR
AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
9M ago
ALVR
AlloVir downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyAlloVir downgraded to Market Perform from Outperform at Leerink
9M ago
ALVR
Nike downgraded, Waste Management upgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike downgraded, Waste Management upgraded: Wall Street’s top analyst calls
9M ago
WM
ADI
Piper cuts AlloVir to Neutral after posoleucel development discontinued
Premium
The Fly
Piper cuts AlloVir to Neutral after posoleucel development discontinued
9M ago
ALVR
AlloVir downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
AlloVir downgraded to Neutral from Overweight at Piper Sandler
9M ago
ALVR
AlloVir downgraded to Underweight from Overweight at JPMorgan
PremiumThe Fly
AlloVir downgraded to Underweight from Overweight at JPMorgan
9M ago
ALVR
AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy
PremiumPress Releases
AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy
9M ago
ALVR
AlloVir to discontinue three global Phase 3 posoleucel studies
PremiumThe Fly
AlloVir to discontinue three global Phase 3 posoleucel studies
9M ago
ALVR
AlloVir reports Q3 EPS (39c), consensus (42c)
PremiumThe FlyAlloVir reports Q3 EPS (39c), consensus (42c)
11M ago
ALVR
ALVR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALVR Upcoming Earnings Report: What to Expect?
11M ago
ALVR
These 2 “Strong Buy” Penny Stocks Could Soar to $17 (Or Higher), Say Analysts
Premium
Stock Analysis & Ideas
These 2 “Strong Buy” Penny Stocks Could Soar to $17 (Or Higher), Say Analysts
1y ago
ALVR
DCTH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >